Pediatric vaccines work as a
protective shield for infants, children and adolescents (age ranging from
0-18 years) against various fatal diseases such as influenza, diphtheria,
hepatitis, meningococcal and pneumococcal diseases etc.
The global pediatric vaccine market was valued at USD 24 Billion in 2015
and is anticipated to exhibit a robust compound annual growth rate (CAGR) of
10.6% over the forecast period. Regionally, the global pediatric
vaccine market is segmented into North America, Latin America, Western
and Eastern Europe, Asia-Pacific and Rest of World. Asia-Pacific is projected
to witness the highest growth rate in pediatric vaccines market in coming 5-6
years.
Market Segmentation
·
By Types
On the basis of technology, the
global pediatric market is segmented into synthetic vaccines, dendritic cells
vaccines, toxoid vaccines, live attenuated vaccines, inactivated vaccines,
subunit vaccines and recombinant vector vaccines.
·
By Diseases
Based on disease the global pediatric
market is segmented into cancer, Hepatitis A, Hepatitis B, Influenza, Polio,
Rotavirus, Tetanus, allergy, infectious disease and other diseases.
Growth Drivers and challenges
Expanding government and private
spending on development of pediatric and other vaccines is a major factor which
is believed to foster the growth of global pediatric market in coming 5-6
years.
However, limited or no access to
healthcare services in developing/under-developed countries, low healthcare
spending, and lower pediatric vaccination coverage etc. are some of the
challenges which might hamper the growth of global pediatric vaccines market in
future.
Market Size and Forecast
North America holds the top rank in pediatric
vaccines market in the world. The pediatric
vaccines market in North America is sparked by higher spending by the
Federal government on healthcare industry. The U.S. and Canada are two major markets
of pediatric vaccines in North America.
Europe pediatric vaccines market is
also propelled by larger government spending on development of medical and
pharmaceutical industry. The market in major European countries such as
Germany, Italy, France, Spain and U.K. is boosted from the funding allotted by
public healthcare services such as NHS (Nation Healthcare Service).
Asia-Pacific pediatric vaccines
market is expected to get escalated by increasing initiatives of World Health organization
(WHO) in countries such as India, China and Japan. In addition to that,
Asia-Pacific pediatric market is also likely to get fostered from strengthening
economic growth of major Asian countries in future.
Key Players
The global pediatric vaccines market
includes some of the top players such as Pfize, Merck, Sanofi Pasteur, Sinovac
Biotech, Bio Med, Valeant Pharmaceuticals, Dynavax Technologies etc.
Scope and Context
Overview of the Parent Market
Analyst View
Market Size and Growth
·
North
America
·
Latin
America
·
Western
and Eastern Europe
·
Asia-Pacific
·
Rest
of World
Segmentation
By
Technology
·
By
Diseases
Market Dynamics
Supply & Demand Risk
Competitive Landscape
Porter’s Five Force Model
Geographical Economic Activity
Key Players (respective SWOT
Analysis) and their Strategies and Product Portfolio
Recent Trends and Developments
Industry Growth Drivers and
Challenges
Key Information for Players to
establish themselves in current dynamic environment
To know more about this research, kindly
visit: http://www.researchnester.com/reports/global-pediatric-vaccines-market-analysis-opportunity-outlook-2021/120
For Table of Content & Free Sample Report Contact:
Ajay Daniel
Email:
ajay.daniel@researchnester.com
U.S. +1 646 586 9123
U.K. +44 203 608 5919